<DOC>
	<DOCNO>NCT00238342</DOCNO>
	<brief_summary>RATIONALE : Finding specific protein blood may help doctor tell whether patient ovarian cancer . PURPOSE : This clinical trial study well proteomic profile work diagnose ovarian cancer patient undergo surgery abnormal pelvic mass .</brief_summary>
	<brief_title>Proteomic Profiling Diagnosing Ovarian Cancer Patients Who Are Undergoing Surgery Abnormal Pelvic Mass</brief_title>
	<detailed_description>OBJECTIVES : Primary - Generate validate serum proteomic profile predict presence invasive ovarian epithelial cancer use preoperative serum specimen obtain patient undergoing surgical evaluation abnormal pelvic mass . Secondary - Generate proteomic profile distinguish early- late-stage invasive ovarian epithelial cancer use preoperative serum specimens patient subsequently diagnose invasive ovarian epithelial cancer . Tertiary - Determine whether serum proteomic profiling predict presence postoperative residual disease patient . - Determine whether serum proteomic profiling predict prognosis patient . OUTLINE : This pilot , two-part , multicenter study . - Part A : Within 3 week prior surgical evaluation , patient undergo collection serum specimen proteomic profile use surface-enhanced matrix-associated laser desorption ionization spectrometry-time flight detection ( SELDI/MALDI-TOF ) . Patients undergo surgical evaluation ( i.e. , biopsy and/or resection ) pelvic mass . Patients diagnose invasive ovarian epithelial adenocarcinoma papillary serous fallopian tube carcinoma ( low malignant potential tumor ) AND without postoperative infection proceed part B study . - Part B : Patients undergo collection postoperative serum specimen proteomic profile use SELDI/MALDI-TOF within 3-8 week surgery , start chemotherapy , end chemotherapy . After completion study procedure , patient follow periodically 10 year . PROJECTED ACCRUAL : A total 2,000 patient accrue study .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Abnormal pelvic mass physical examination image test Undiagnosed Planning undergo surgical evaluation within next 3 week PATIENT CHARACTERISTICS : Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Negative pregnancy test PRIOR CONCURRENT THERAPY : Surgery See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>stage I ovarian epithelial cancer</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>ovarian clear cell cystadenocarcinoma</keyword>
	<keyword>ovarian endometrioid adenocarcinoma</keyword>
	<keyword>ovarian mucinous cystadenocarcinoma</keyword>
	<keyword>ovarian serous cystadenocarcinoma</keyword>
	<keyword>ovarian undifferentiated adenocarcinoma</keyword>
</DOC>